In the next 5 years, the market is expected to grow to $105 billion, representing a 17.5x increase in market value: By 2030, the US GLP-1 patient pool will include 15 million people, representing 9% of Americans with diet-related diseases
, adenosine deaminase (ADA), caveolin-1, streptokinase, and plasminogen) and components of the extracellular matrix ( e.g
Through the program, which runs through December 31, 2027, eligible Medicare beneficiaries can access certain GLP1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify
Lipoprotein(a): resurrected by genetics
Disruptions in GI health are more likely in individuals with genetic predispositions to certain diseases